Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases
Journal:
Current Drug Targets
Volume:
8
Page:
217-235
Author(s):
M. A. Morgan, A. Ganser and C. W. M. Reuter
Oncogenic Signaling in Acute Myeloid Leukemia
Journal:
Current Drug Targets
Volume:
8
Page:
237-246
Author(s):
Christian H. Brandts, Wolfgang E. Berdel and Hubert Serve
Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies
Journal:
Current Drug Targets
Volume:
8
Page:
257-268
Author(s):
Torsten Kessler, Frauke Fehrmann, Ralf Bieker, Wolfgang E. Berdel and Rolf M. Mesters
Role of Cathepsin K in Normal Joints and in the Development of Arthritis
Journal:
Current Drug Targets
Volume:
8
Page:
315-323
Author(s):
H. J. Salminen-Mankonen, J. Morko and E. Vuorio
Anabolic Factors in Degenerative Joint Disease
Journal:
Current Drug Targets
Volume:
8
Page:
359-365
Author(s):
L. J. Sandell
Tyrosine Kinases as Targets for Anti-Inflammatory Therapy
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
6
Page:
47-60
Author(s):
Teruko Tamura and Alexandra Koch
T Cell Costimulatory and Inhibitory Receptors as Therapeutic Targets for Inducing Anti-Tumor Immunity
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
55-70
Author(s):
Jeurgen Foell and Becker Hewes
Small Molecule Inhibitors of Stat3 Signaling Pathway
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
91-107
Author(s):
Jinxia Deng, Fedora Grande and Nouri Neamati
Fusions Involving PAX and FOX Genes in the Molecular Pathogenesis of Alveolar Rhabdomyosarcoma: Recent Advances
Journal:
Current Molecular Medicine
Volume:
7
Page:
47-61
Author(s):
Gabriela E. Mercado and Frederic G. Barr
Tyrosine Kinase Mutations in Human Cancer
Journal:
Current Molecular Medicine
Volume:
7
Page:
77-84
Author(s):
Ernst Lengyel, Kenjiro Sawada and Ravi Salgia